- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
1PE.2: 10 residues within 4Å:- Chain A: I.273, R.274, W.276, E.277, Y.302, L.305, E.306, R.309, L.310
- Chain D: Q.282
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.277, A:E.306, A:R.309, A:R.309
1PE.19: 10 residues within 4Å:- Chain B: Q.282
- Chain C: I.273, R.274, W.276, E.277, Y.302, L.305, E.306, R.309, L.310
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:E.277, C:E.306, C:R.309, C:R.309
- 26 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 8 residues within 4Å:- Chain A: E.338, I.341, T.381, N.387
- Chain B: Q.265, H.313, H.317
- Ligands: GOL.14
Ligand excluded by PLIPGOL.4: 6 residues within 4Å:- Chain A: A.156, S.157, R.192, P.195, A.197, K.199
Ligand excluded by PLIPGOL.5: 8 residues within 4Å:- Chain A: I.144, Y.146, L.258, E.261, A.383, G.384
- Ligands: FDA.1, GOL.6
Ligand excluded by PLIPGOL.6: 8 residues within 4Å:- Chain A: G.152, T.153, L.155, L.258, G.385, V.386
- Ligands: FDA.1, GOL.5
Ligand excluded by PLIPGOL.7: 9 residues within 4Å:- Chain A: D.297, R.300, D.342, R.345, T.346
- Chain B: E.306, A.347, S.348
- Ligands: GOL.16
Ligand excluded by PLIPGOL.8: 7 residues within 4Å:- Chain A: Q.291, W.293
- Chain B: D.130, A.349, Q.352, R.353, D.356
Ligand excluded by PLIPGOL.9: 7 residues within 4Å:- Chain A: Q.101, R.102, R.271, R.274, L.275, D.278, Q.369
Ligand excluded by PLIPGOL.10: 9 residues within 4Å:- Chain A: R.50, G.53, E.54, R.271, P.359, Q.369, Q.372, L.373, Q.376
Ligand excluded by PLIPGOL.12: 10 residues within 4Å:- Chain B: D.268, I.271, E.272, R.314
- Chain C: K.304, A.334, Y.335, E.338, R.391
- Ligands: GOL.13
Ligand excluded by PLIPGOL.13: 9 residues within 4Å:- Chain B: E.272, W.302, W.303, E.306, N.310, R.314
- Chain C: K.304, Y.335
- Ligands: GOL.12
Ligand excluded by PLIPGOL.14: 6 residues within 4Å:- Chain A: R.345
- Chain B: E.306, N.310, H.313, R.314
- Ligands: GOL.3
Ligand excluded by PLIPGOL.15: 7 residues within 4Å:- Chain B: W.88, S.194, D.196, L.227, W.336, Q.339, I.340
Ligand excluded by PLIPGOL.16: 11 residues within 4Å:- Chain A: R.345, T.348, G.349
- Chain B: D.305, L.309, K.338, S.341, G.342, G.346, A.347
- Ligands: GOL.7
Ligand excluded by PLIPGOL.20: 8 residues within 4Å:- Chain C: E.338, I.341, T.381, N.387
- Chain D: Q.265, H.313, H.317
- Ligands: GOL.31
Ligand excluded by PLIPGOL.21: 6 residues within 4Å:- Chain C: A.156, S.157, R.192, P.195, A.197, K.199
Ligand excluded by PLIPGOL.22: 8 residues within 4Å:- Chain C: I.144, Y.146, L.258, E.261, A.383, G.384
- Ligands: FDA.18, GOL.23
Ligand excluded by PLIPGOL.23: 8 residues within 4Å:- Chain C: G.152, T.153, L.155, L.258, G.385, V.386
- Ligands: FDA.18, GOL.22
Ligand excluded by PLIPGOL.24: 9 residues within 4Å:- Chain C: D.297, R.300, D.342, R.345, T.346
- Chain D: E.306, A.347, S.348
- Ligands: GOL.33
Ligand excluded by PLIPGOL.25: 7 residues within 4Å:- Chain C: Q.291, W.293
- Chain D: D.130, A.349, Q.352, R.353, D.356
Ligand excluded by PLIPGOL.26: 7 residues within 4Å:- Chain C: Q.101, R.102, R.271, R.274, L.275, D.278, Q.369
Ligand excluded by PLIPGOL.27: 9 residues within 4Å:- Chain C: R.50, G.53, E.54, R.271, P.359, Q.369, Q.372, L.373, Q.376
Ligand excluded by PLIPGOL.29: 10 residues within 4Å:- Chain A: K.304, A.334, Y.335, E.338, R.391
- Chain D: D.268, I.271, E.272, R.314
- Ligands: GOL.30
Ligand excluded by PLIPGOL.30: 9 residues within 4Å:- Chain A: K.304, Y.335
- Chain D: E.272, W.302, W.303, E.306, N.310, R.314
- Ligands: GOL.29
Ligand excluded by PLIPGOL.31: 6 residues within 4Å:- Chain C: R.345
- Chain D: E.306, N.310, H.313, R.314
- Ligands: GOL.20
Ligand excluded by PLIPGOL.32: 7 residues within 4Å:- Chain D: W.88, S.194, D.196, L.227, W.336, Q.339, I.340
Ligand excluded by PLIPGOL.33: 11 residues within 4Å:- Chain C: R.345, T.348, G.349
- Chain D: D.305, L.309, K.338, S.341, G.342, G.346, A.347
- Ligands: GOL.24
Ligand excluded by PLIP- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.11: 4 residues within 4Å:- Chain A: V.57, P.108, V.110, T.111
Ligand excluded by PLIPCL.17: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.28: 4 residues within 4Å:- Chain C: V.57, P.108, V.110, T.111
Ligand excluded by PLIPCL.34: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stirling, A.J. et al., A Key Glycine in Bacterial Steroid-Degrading Acyl-CoA Dehydrogenases Allows Flavin-Ring Repositioning and Modulates Substrate Side Chain Specificity. Biochemistry (2020)
- Release Date
- 2020-10-28
- Peptides
- Acyl-CoA dehydrogenase domain protein Tcur3483: AC
Acyl-CoA dehydrogenase domain protein Tcur3481: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 26 x GOL: GLYCEROL(Non-functional Binders)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stirling, A.J. et al., A Key Glycine in Bacterial Steroid-Degrading Acyl-CoA Dehydrogenases Allows Flavin-Ring Repositioning and Modulates Substrate Side Chain Specificity. Biochemistry (2020)
- Release Date
- 2020-10-28
- Peptides
- Acyl-CoA dehydrogenase domain protein Tcur3483: AC
Acyl-CoA dehydrogenase domain protein Tcur3481: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
BD
B